



Silence Therapeutics, a biotechnology company, has placed 9.5m new ordinary shares at 200p each and announced plans for a share consolidation. The p...


UK small caps advances 0.3 percent in midday trade, underperforming a 1 percent rise from the mid-caps, and a 0.9 percent gain from the blue chips. Si...


March 5 (Reuters) - Biotech research and development company Silence Therapeutics said it received approval from German authorities for trials of its ...


Silence Therapeutics has unveiled Michael Khan as the company's new Chief Medical Officer. He will oversee the phase II study on ATU027 for cancer an...


The FTSE Small Caps index jumps 1.1 percent by midday on the first session of 2013, but still underperforms bigger gains by the FTSE 100 and FTSE 250...